Clinical Trials on Lung Cancer, Nonsmall Cell in United Kingdom
Total 7369 results
-
Georgetown UniversityMacroGenicsRecruitingExtensive-stage Small-cell Lung CancerUnited States
-
Hirva MamdaniAstraZeneca; Barbara Ann Karmanos Cancer InstituteRecruitingSmall Cell Lung Cancer | SCLC | Extensive Stage Small Cell Lung CancerUnited States
-
Medical University of South CarolinaAltor BioScienceCompletedNon-small Cell Lung CancerUnited States
-
Lycera Corp.UnknownNon-small Cell Lung CancerUnited States
-
AbbottCompletedNon-small Cell Lung CancerUnited States
-
Illinois CancerCare, P.C.TerminatedNon Small Cell Lung CancerUnited States
-
Cellectar Biosciences, Inc.CompletedNon Small Cell Lung CancerUnited States, Israel, Canada, Spain, Russian Federation, Serbia, Italy, Poland, Romania, Switzerland, Ukraine, United Kingdom
-
Revolution Medicines, Inc.RecruitingNon-Small Cell Lung Cancer, NSCLC | KRAS, NRAS, HRAS-mutated NSCLC | KRAS G12C-mutated Solid Tumors, Lung Cancer | Lung Cancer Stage IV, Advanced Solid Tumor, CancerUnited States
-
University of BirminghamAstraZeneca; Cancer Research UKCompletedLarynx Cancer | Oral Cavity Squamous Cell Carcinoma | Hypopharynx Squamous Cell CarcinomaUnited Kingdom
-
Hoffmann-La RocheJazz PharmaceuticalsActive, not recruitingSmall-Cell Lung CancerUnited States, Belgium, Italy, Spain, Turkey, United Kingdom, Korea, Republic of, Germany, Mexico, Hungary, Taiwan, Greece, Poland
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Unresectable Malignant Neoplasm | Metastatic Neoplasm | Recurrent NeoplasmUnited States
-
Gilead SciencesMerck Sharp & Dohme LLCActive, not recruitingNon-small Cell Lung CancerUnited States, Spain, Italy, France, Australia, Hong Kong, Korea, Republic of, Malaysia, Taiwan, Germany, United Kingdom, Canada
-
Cardiff UniversityCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited Kingdom
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)RecruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage... and other conditionsUnited States
-
University of Texas Southwestern Medical CenterKaryopharm Therapeutics IncTerminatedNon-small Cell Lung CancerUnited States
-
Clovis Oncology, Inc.Novartis PharmaceuticalsTerminated
-
PfizerCompletedNon Small Cell Lung CancerUnited States, Australia
-
M.D. Anderson Cancer CenterTerminatedSmall Cell Lung Cancer | Lung Cancer | Non-small Cell Lung Cancer | Carcinoid | Thymic CancerUnited States
-
Texas A&M UniversityUniversity of ArkansasUnknownNon-small Cell Lung CancerUnited States
-
University of FloridaCompletedNon-small Cell Lung CancerUnited States
-
Kadmon Corporation, LLCCompleted
-
Teesside UniversityBarts & The London NHS Trust; South Tees Hospitals NHS Foundation TrustCompletedLung Cancer | Surgery | Thoracic CancerUnited Kingdom
-
Massachusetts General HospitalCompleted
-
Aptium Oncology Research NetworkMillennium Pharmaceuticals, Inc.UnknownNon-small Cell Lung CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)Active, not recruitingStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Recurrent Head and Neck Carcinoma | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | ALK Gene Mutation | EGFR Gene Mutation | Metastatic Head and Neck... and other conditionsUnited States
-
Washington University School of MedicineCompletedInoperable Stage I/II Non-small Cell Lung CancerUnited States
-
OSI PharmaceuticalsCompletedAdvanced Non Small Cell Lung Cancer | Failed Prior ChemotherapyUnited States
-
AmgenActive, not recruitingRelapsed/Refractory Small Cell Lung CancerUnited States, Belgium, Italy, Spain, Portugal, Austria, Greece, Korea, Republic of, Denmark, Netherlands, Germany, France, Taiwan, Japan, United Kingdom, Poland, Switzerland, Singapore
-
Daiichi SankyoDaiichi Sankyo Co., Ltd.Active, not recruitingNon-Small Cell Lung Cancer Metastatic | Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor ReceptorUnited States, Spain, Korea, Republic of, France, United Kingdom, Taiwan, Australia, Japan, China, Netherlands, Italy, Germany, Austria, Belgium, Bulgaria, Singapore
-
HUYABIO International, LLC.Active, not recruitingNon Small Cell Lung CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingNon-small Cell Lung Cancer | Non Small Cell Lung Cancer Metastatic | Minimal Residual Disease | NSCLC Stage IV | Nsclc | Metastatic Non Small Cell Lung CancerUnited States
-
Genprex, Inc.RecruitingNon Small Cell Lung CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsActive, not recruitingNon-small Cell Lung CancerUnited States
-
Hoffmann-La RocheTerminatedNon-Squamous Non-Small Cell Lung CancerUnited States, Italy, Belgium, Germany, Spain, Australia, Canada, United Kingdom, France, Poland, Ireland
-
UNC Lineberger Comprehensive Cancer CenterG1 Therapeutics, Inc.Recruiting
-
Mayo ClinicMedical University of South CarolinaTerminatedNon Small Cell Lung CancerUnited States
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung CancerSpain, France, United States, Taiwan, United Kingdom, Philippines, Latvia, Italy, Israel, Argentina, Mexico, Germany, Malaysia
-
University of California, DavisNational Cancer Institute (NCI); Novartis PharmaceuticalsCompletedRecurrent Non-small Cell Lung CancerUnited States
-
VA Office of Research and DevelopmentNational Cancer Institute (NCI); Jonsson Comprehensive Cancer CenterTerminatedNon-Small Cell Lung Cancer (NSCLC)United States
-
University of Alabama at BirminghamSanofiCompletedNon-small Cell Lung Cancer (NSCLC) | Metastatic NSCLC | Stage IV NSCLCUnited States
-
Muhammad FurqanAstraZenecaRecruitingExtensive Stage Small Cell Lung CancerUnited States
-
Georgetown UniversityGenentech, Inc.RecruitingNon-squamous Non-small-cell Lung CancerUnited States
-
Andrew SharabiPfizerTerminatedEarly Stage Non-Small Cell Lung CancerUnited States
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung CancerUnited States, France, Netherlands
-
Greg Durm, MDMerck Sharp & Dohme LLC; Big Ten Cancer Research ConsortiumCompleted
-
Jennifer BellEmory University; University of Virginia; University of North CarolinaCompletedNon-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedLung Metastases | Extensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung Cancer | Malignant Pleural EffusionUnited States
-
M.D. Anderson Cancer CenterNational Heart, Lung, and Blood Institute (NHLBI)RecruitingStage III Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage IIIC Lung Cancer AJCC v8 | Locally Advanced Lung Non-Small Cell CarcinomaUnited States
-
BIND TherapeuticsCompletedSquamous Cell Non-small Cell Lung Cancer | KRAS Positive Patients With Non-small Cell Lung CancerUnited States, Russian Federation
-
Georgetown UniversityBristol-Myers Squibb; Advanced Accelerator ApplicationsCompletedSmall Cell Lung Cancer | Small Cell Lung Cancer Extensive StageUnited States